Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study.
Ram A Sharma1, Andrew W Varga2, Omonigho M Bubu3
11 Center for Brain Health, Department of Psychiatry, and.
American Journal of Respiratory and Critical Care Medicine
|November 11, 2017
Summary
Obstructive sleep apnea (OSA) severity is linked to increased amyloid-beta in cognitively normal elderly. This suggests sleep apnea may accelerate Alzheimer's disease risk by promoting amyloid buildup.
Area of Science:
- Neurology
- Sleep Medicine
- Gerontology
Background:
- Obstructive sleep apnea (OSA) is increasingly recognized as a potential risk factor for cognitive decline, including Alzheimer's disease.
- The specific impact of OSA severity on the longitudinal progression of Alzheimer's disease biomarkers remains less understood.
Purpose of the Study:
- To investigate the association between the severity of obstructive sleep apnea and the longitudinal increase in amyloid burden among cognitively normal elderly individuals.
- To test the hypothesis that greater OSA severity correlates with accelerated amyloid deposition in the brain.
Main Methods:
- A 2-year prospective longitudinal study involving healthy, cognitively normal elderly volunteers (aged 55-90).
- Measurement of cerebrospinal fluid (CSF) amyloid-beta (Aβ) using ELISA and brain amyloid deposition via Pittsburgh Compound B (PiB) positron emission tomography (PET) scans.
- Assessment of OSA severity using home sleep recording devices, analyzing indices like AHIall and AHI4%.
Main Results:
- Higher severity of OSA, indicated by AHIall and AHI4% indices, was significantly associated with the annual rate of change in CSF Aβ42 levels.
- No significant association was found between OSA severity and increases in brain amyloid deposition (AD-PiB-mask), potentially due to the study's small sample size, although a trend was observed.
Conclusions:
- In cognitively normal elderly individuals, OSA is associated with biomarkers indicating increased amyloid burden over a 2-year period.
- Sleep fragmentation and intermittent hypoxia resulting from OSA are proposed as potential mechanisms driving amyloid accumulation.
- These findings suggest that interventions targeting OSA could be beneficial in preventing or slowing amyloid buildup, potentially mitigating Alzheimer's disease risk.
Related Concept Videos
Sleep Apnea
605
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
605
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K


